Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Bumadizone calcium
RN: 34461-73-9
UNII: 142R7TU2TN
InChIKey: RKINNRASCJRSHD-UHFFFAOYSA-L

Classification Codes

  • Drug / Therapeutic Agent
  • Reproductive Effect

Molecular Formulas

  • C19-H22-N2-O3.1/2Ca
  • C38-H42-N4-O6.Ca

Molecular Weight

  • 690.85
 
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Results Name

  • Bumadizone calcium

Name of Substance

  • Bumadizone calcium anhydrous

Synonyms

  • B-64114 Co
  • Bumadizon calcium
  • Bumadizone calcium
  • Butyl-malonsaure-mono-(1,2-diphenyl-hydrazid)-calzium
  • Butyl-malonsaure-mono-(1,2-diphenyl-hydrazid)-calzium [German]
  • Butylmalonic acid mono(1,2-diphenylhydrazide) calcium
  • Calcium-N-n-butylmalonic acid N,N'-diphenylhydrazide
  • EINECS 252-048-9
  • Eumotol
  • UNII-142R7TU2TN

Systematic Names

  • Calcium bis(2-butyl-3-(1,2-diphenylhydrazino)-3-oxopropionate)
  • Malonic acid, butyl-, mono(1,2-diphenylhydrazide), calcium salt (2:1)
  • Propanedioic acid, butyl-, mono(1,2-diphenylhydrazide), calcium salt (2:1) (9CI)

Registry Numbers

CAS Registry Number

  • 34461-73-9

FDA UNII

  • 142R7TU2TN

Related Registry Number

  • 3583-64-0 (Parent)

System Generated Number

  • 0034461739

Molecular Formulas

Molecular Formulas

  • C19-H22-N2-O3.1/2Ca
  • C38-H42-N4-O6.Ca

Molecular Formula Fragments

  • C19-H22-N2-O3
  • C38-H42-N4-O6
  • Ca
  • COMPONENT

Structure Descriptors

InChI

1S/2C19H22N2O3.Ca/c2*1-2-3-14-17(19(23)24)18(22)21(16-12-8-5-9-13-16)20-15-10-6-4-7-11-15;/h2*4-13,17,20H,2-3,14H2,1H3,(H,23,24);/q;;+2/p-2

InChIKey

RKINNRASCJRSHD-UHFFFAOYSA-L

Smiles

N(c1ccccc1)(C([C@@H](CCCC)C(=O)[O-])=O)Nc1ccccc1.N(c1ccccc1)(C([C@@H](CCCC)C(=O)[O-])=O)Nc1ccccc1.[Ca+2]

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 440mg/kg (440mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 67, Pg. 337, 1971.
mouse LD50 oral 1500mg/kg (1500mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 67, Pg. 337, 1971.
rat LD50 intraperitoneal 350mg/kg (350mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 67, Pg. 337, 1971.
rat LD50 oral 750mg/kg (750mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 67, Pg. 337, 1971.